Hauser's FDA Rx: The FDA needs an NTSB

March 10, 2013 by Arezu Sarvestani

Post-approval medical device and pharmaceutical surveillance duties should be taken away from the FDA, says long-time patient safety advocate and FDA critic Dr. Robert Hauser, who's advocating for an independent bureau akin to the National Transportation Safety Board.

Dr. Robert Hauser

Dr. Robert Hauser hopes to push a major change at the FDA, looking to shift the monitoring of medical devices and drugs that are already on the market from the FDA to an independent entity.

Hauser, a long-time patient safety advocate and vocal FDA critic, is aiming to sell Capitol Hill on a new structure for the U.S. healthcare regulation system akin to how the nation deals with transportation safety, he told in an exclusive interview.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.